Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
MGX Metagenomi Technologies
- 1.690
- -0.050-2.87%
Close Apr 28 16:00 ET
- 1.690
- 0.0000.00%
Post 16:05 ET
63.18MMarket Cap-0.81P/E (TTM)
1.780High1.610Low251.51KVolume1.740Open1.740Pre Close421.18KTurnover1.08%Turnover RatioLossP/E (Static)37.38MShares8.17552wk High0.27P/B39.40MFloat Cap1.23052wk Low--Dividend TTM23.31MShs Float12.740Historical High--Div YieldTTM9.77%Amplitude1.230Historical Low1.674Avg Price1Lot Size
About Metagenomi Technologies Company
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Company Profile
SymbolMGX
Company NameMetagenomi Technologies
Listing DateFeb 9, 2024
Issue Price15.00
Founded2016
CEODr. Brian C. Thomas, PhD
MarketNASDAQ
Employees202
Fiscal Year Ends12-31
Address5959 Horton Street,7th floor
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-871-4880
Websitehttp://www.metagenomi.co
Company Executives
- Name
- Position
- Salary
- Dr. Brian C. Thomas, PhD
- Chief Executive Officer and Chairman of the Board
- 6.06M
- Pamela Wapnick, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- 3.58M
- Dr. Sarah B. Noonberg, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Jian Irish, M.B.A.,PhD
- President, Chief Operating Officer and Director
- 3.78M
- Matthew L. Wein, J.D.
- Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
- --
- Eric H. Bjerkholt, M.B.A.
- Independent Director
- --
- Dr. Willard H. Dere, M.D.
- Lead Independent Director
- 663.44K
- Dr. Sebastian Bernales, PhD
- Independent Director
- 657.99K
- Dr. Juergen Eckhardt, M.B.A.,M.D.
- Independent Director
- 660.22K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call